Simcere Zaiming

Simcere zaiming email format

Verified email-pattern data for Simcere Zaiming is currently limited. You can still use the company insights and contact sections below.
Simcere Zaiming is a pharmaceutical company specializing in oncology, and a subsidiary of Simcere Pharmaceutical Group Limited, that focuses on the R&D, production and commercialization of innovative cancer therapeutics. The company was formed in 2023 and is committed to solving unmet clinical needs for cancer patients in China and around the world by developing breakthrough treatments. Simcere Zaiming has an innovative R&D pipeline with differentiated clinical value, among which 15 assets are currently in clinical trials. In addition to the company’s R&D portfolio, Simcere Zaiming is marketing three innovative drugs, COSELA®, Endostar®, and Envafolimab®. By collaborating with partners globally, Simcere Zaiming strives to bring potentially new innovative therapeutics to cancer patients worldwide.

Company Details

Employees
35
Founded
-
Address
玄武大道, 699-18号 23号楼,china
Industry
Pharmaceutical Manufacturing
HQ
南京, 江苏
Looking for a particular Simcere Zaiming employee's phone or email?

Simcere Zaiming Questions

Explore related pages

Related company profiles:

Top Simcere Zaiming Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant